663. Epidemiology and outcomes of recurrent C. difficile infection among hematopoietic cell transplant recipients

BACKGROUND: Recent updates in Clostridioides difficile infection (CDI) treatment guidelines among hematopoietic cell transplant (HCT) recipients recommend fidaxomicin as first line therapy as it reduces the risk of recurrent CDI. We aimed to characterize HCT recipients with CDI and describe their cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez, Eduardo, Krantz, Elizabeth M, Pergam, Steven A, Liu, Catherine, Tverdek, Frank P, Escobar, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677654/
http://dx.doi.org/10.1093/ofid/ofad500.726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677654/
http://dx.doi.org/10.1093/ofid/ofad500.726

Ejemplares similares